48 results
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
continues to be effective and that they continue to demonstrate commitment to their roles. The Board considers that it is entirely appropriate for each … and professional ethics, integrity and values;
commitment to representing the long-term interests of the Company’s shareholders;
independence under
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
commitment to expedite the development and review of the product candidate, including involvement of senior managers.
Product candidates studied … on an efficient drug development program, beginning as early as Phase 1; organizational commitment involving senior managers; and eligibility
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
28 Oct 22
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
7:11am
shareholders. I also want to thank our outgoing directors, each of whom has been instrumental in getting Mereo to where it is today, for their commitment
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
28 Oct 22
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
7:11am
or cancellation of, the Articles or any agreement, contract, commitment, understanding or arrangement to which the Company is a party or by which … , acceleration or cancellation of, any organizational document, agreement, contract, commitment, understanding or arrangement to which it is a party
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
to shepherd the successful execution of this strategy.
Mereo welcomes the views of all shareholders and maintains its strong commitment to considering … directors in total since 2019, demonstrating our commitment to best corporate governance practices, which includes the separation of the Chairman
6-K
EX-99.1
3ail pvvg6
18 Oct 22
Mereo BioPharma Announces Updated Operating Plan to Maximize Shareholder Value
7:07am
6-K
EX-99.1
qqyos4wd8h8vgxu3 8dq
31 Aug 22
Letter Reiterates Mereo’s Updated Strategic Plan to Maximize Value for All Shareholders and Corrects Rubric’s Assumptions
7:57am
6-K
EX-99.1
bnirx9
17 May 22
Mereo BioPharma Announces Appointment of Dr. Abdul Mullick to Board of Directors
8:19am
6-K
EX-99.1
3cd3fc16mokld2ptw
9 May 22
Current report (foreign)
8:06am
CORRESP
fjr2gv i80f0qxjyv
7 Sep 21
Correspondence with SEC
12:00am
424B5
05e3m
10 Feb 21
Prospectus supplement for primary offering
4:53pm
424B5
oqayd5nn3wc
9 Feb 21
Prospectus supplement for primary offering
5:24pm
6-K
EX-99.2
2vq 1ocupvn7sac
29 Sep 20
Current report (foreign)
7:08am
POS AM
amn8a8
2 Jul 20
Prospectus update (post-effective amendment)
3:57pm
6-K
11nb 660yh3m
16 Jun 20
Current report (foreign)
4:13pm
6-K
EX-10.1
mp1n2k
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am